ONCHOCERCIASIS
Clinical trials for ONCHOCERCIASIS explained in plain language.
Never miss a new study
Get alerted when new ONCHOCERCIASIS trials appear
Sign up with your email to follow new studies for ONCHOCERCIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Massive trial tests safer river blindness drug in nearly 13,000 people
Disease control CompletedThis study tested the safety of a single dose of moxidectin compared to ivermectin in nearly 13,000 people living in areas where river blindness is common. Some participants also received albendazole for a related infection. The goal was to see if moxidectin causes fewer or less …
Matched conditions: ONCHOCERCIASIS
Phase: PHASE3 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
River blindness drug dose for kids tested in new study
Knowledge-focused CompletedThis study tested a single dose of moxidectin in 36 children aged 4 to 17 years living in areas with river blindness (onchocerciasis). The goal was to find a dose for children 4-11 years that works as well as the 8 mg dose used in older people. Researchers measured drug levels in…
Matched conditions: ONCHOCERCIASIS
Phase: PHASE1 • Sponsor: Medicines Development for Global Health • Aim: Knowledge-focused
Last updated May 26, 2026 09:41 UTC